Larson Financial Group LLC Boosts Stock Holdings in Aflac Incorporated (NYSE:AFL)

Larson Financial Group LLC boosted its position in Aflac Incorporated (NYSE:AFL) by 12.2% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 35,182 shares of the financial services provider’s stock after buying an additional 3,819 shares during the quarter. Larson Financial Group LLC’s holdings in Aflac were worth $3,933,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently made changes to their positions in the company. Y.D. More Investments Ltd bought a new stake in Aflac in the 2nd quarter valued at about $25,000. Darwin Wealth Management LLC purchased a new position in shares of Aflac in the third quarter worth about $34,000. Covestor Ltd raised its position in shares of Aflac by 41.8% in the third quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock valued at $41,000 after purchasing an additional 107 shares during the period. Kennebec Savings Bank bought a new stake in shares of Aflac in the third quarter valued at approximately $45,000. Finally, Catalyst Capital Advisors LLC purchased a new stake in shares of Aflac during the 3rd quarter valued at approximately $51,000. 67.44% of the stock is currently owned by institutional investors.

Aflac Stock Up 0.6 %

AFL opened at $112.39 on Friday. The business’s fifty day simple moving average is $110.73 and its 200 day simple moving average is $100.55. Aflac Incorporated has a 52 week low of $75.07 and a 52 week high of $115.50. The company has a quick ratio of 0.08, a current ratio of 0.08 and a debt-to-equity ratio of 0.32. The stock has a market cap of $62.44 billion, a PE ratio of 16.93, a P/E/G ratio of 2.15 and a beta of 0.96.

Aflac (NYSE:AFL) last issued its earnings results on Wednesday, October 30th. The financial services provider reported $2.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.69 by $0.47. Aflac had a return on equity of 16.34% and a net margin of 22.02%. The business had revenue of $2.95 billion during the quarter, compared to analyst estimates of $4.30 billion. During the same quarter in the prior year, the firm earned $1.84 earnings per share. Aflac’s revenue for the quarter was down 40.4% on a year-over-year basis. As a group, research analysts expect that Aflac Incorporated will post 7.22 earnings per share for the current fiscal year.

Aflac Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 2nd. Stockholders of record on Wednesday, November 20th will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Wednesday, November 20th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.78%. Aflac’s dividend payout ratio (DPR) is currently 30.12%.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on AFL. Piper Sandler lifted their price objective on shares of Aflac from $114.00 to $122.00 and gave the company an “overweight” rating in a research note on Wednesday, October 2nd. Barclays initiated coverage on Aflac in a research report on Wednesday, September 4th. They issued an “underweight” rating and a $96.00 price target for the company. Morgan Stanley raised their target price on Aflac from $91.00 to $98.00 and gave the stock an “equal weight” rating in a research note on Monday, August 19th. TD Cowen began coverage on Aflac in a report on Wednesday, October 9th. They set a “hold” rating and a $102.00 target price for the company. Finally, Bank of America increased their price target on shares of Aflac from $115.00 to $124.00 and gave the stock a “buy” rating in a report on Thursday, October 10th. Three research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, Aflac currently has an average rating of “Hold” and an average price target of $97.93.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.